Results 131 to 140 of about 19,663 (194)

Alectinib shows promise for the treatment of refractory ALK-positive large B-cell lymphoma: a case report. [PDF]

Front Oncol
Alsulami A, Almufti R, Eldadah S, Al-Ghamdi Y.   +3 more
europepmc   +1 more source

Refining first-line therapy in ALK-positive non-small cell lung cancer: final overall survival from the ALEX trial and an evolving treatment landscape. [PDF]

J Thorac Dis
Boshkos M, Parma M, Singhi EK.
europepmc   +1 more source

c-Met-targeted NIR-II imaging for precision management of oral squamous cell carcinoma and premalignant lesions. [PDF]

Theranostics
Xia Z, Ji A, Ma Q, Li Y, Lou H, Qian K, Tian J, Yuan Y, Cheng Z, Tao X.   +9 more
europepmc   +1 more source

Research progress on resistance and mechanisms of c-Met inhibitors in treating <i>MET</i> exon 14 skipping mutant non-small cell lung cancer: a narrative review. [PDF]

J Thorac Dis
Bu Y, Song W, Wang Y, Che G.
europepmc   +1 more source

Inflammatory myofibroblastic tumour: unravelling the interplay of inflammation, kinase signalling, and therapeutic resistance. [PDF]

Front Oncol
Maiti S, Reji AR, Senthil S, R R, Solairaju R, Kunjumon R, Ghosh P, H P S, Sadhukhan P, Dutta A.   +9 more
europepmc   +1 more source

Priming Cells with Modulators of Cellular Signaling Ensures Enhanced Selectivity of HSPG-Specific Protein-Drug Conjugate Delivery. [PDF]

J Am Chem Soc
Chorążewska A, Ciura K, Milczarek M, Kłopotowska D, Pomorski A, Więch-Walów A, Łukianowski B, Gajdzis P, Krężel A, Bartoszewski R, Wietrzyk J, Schaefer L, Porębska N, Opaliński Ł.   +13 more
europepmc   +1 more source

Clinical characteristics of ALK-positive NSCLC patients treated with sequential ALK-TKI therapies in a single-centre. [PDF]

Lung Cancer Manag
Fujita K, Imakita T, Fujimoto N, Yoshimura S, Toyama S, Ito T, Oi I, Kanai O, Yamamoto Y, Tanizawa K.   +9 more
europepmc   +1 more source

In vitro and in silico modelling of ROS1-positive non-small cell lung cancer reveals fusion-dependent tyrosine kinase inhibitor responses. [PDF]

Mol Oncol
Ul Haq F, Terrones M, Rodrigues Fortes F, Schepers A, Denis A, Deben C, Op de Beeck K, Van Camp G, Vandeweyer G.   +8 more
europepmc   +1 more source

Molecularly guided management of pediatric endobronchial inflammatory myofibroblastic tumor: a report of two cases on surgical and targeted intervention. [PDF]

Transl Pediatr
Ke L, Li S, Wu L, Zhu G.
europepmc   +1 more source

Targeted immunotherapies for anaplastic lymphoma kinase-positive pediatric tumors: current advances and future perspectives. [PDF]

Front Immunol
Maccagno M, Tagliero R, Chiarle R, Voena C.   +3 more
europepmc   +1 more source